Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets. [electronic resource]
Producer: 20180724Description: 952-959 p. digitalISSN:- 1873-7560
- Adult
- Aged
- Aged, 80 and over
- Antigens, Nuclear -- genetics
- Antineoplastic Agents, Immunological -- therapeutic use
- BCG Vaccine -- therapeutic use
- Biomarkers
- Cell Cycle Proteins
- Class I Phosphatidylinositol 3-Kinases -- genetics
- Cystectomy
- DNA Copy Number Variations
- DNA Damage -- genetics
- DNA Repair -- genetics
- DNA-Binding Proteins
- Exons
- Female
- Gene Fusion
- High-Throughput Nucleotide Sequencing
- Histone Demethylases -- genetics
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Molecular Targeted Therapy
- Mutation
- Neoplasm Grading
- Neoplasm Invasiveness
- Neoplasm Recurrence, Local -- genetics
- Neoplasm Staging
- Nuclear Proteins -- genetics
- Proportional Hazards Models
- Receptor, ErbB-2 -- genetics
- Receptor, Fibroblast Growth Factor, Type 3 -- genetics
- Telomerase -- genetics
- Transcription Factors -- genetics
- Tumor Suppressor Protein p53 -- genetics
- Urinary Bladder Neoplasms -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.